Zevia PBC filings document the public-company disclosures of a Delaware public benefit corporation focused on zero-sugar, clean-label beverages. Form 8-K reports furnish quarterly and annual earnings releases, Regulation FD investor presentations, board appointments and committee assignments, and material agreements tied to the company’s capital structure.
Proxy materials describe annual meeting matters such as director elections, auditor ratification, board structure, committee oversight and stockholder voting procedures. Other filings address the company’s Class A common stock, its wholly owned subsidiary Zevia LLC, and equity distribution arrangements used for at-the-market offering capacity.
Zevia PBC President & CEO Amy Taylor reported a mix of equity awards and related share sales. On March 26, she received 1,021,277 restricted stock units (RSUs) under the 2021 Equity Incentive Plan, each convertible into one Class A share and vesting in four annual installments starting March 26, 2026.
To cover tax liabilities from the settlement of earlier RSU grants totaling 169,394 and 202,882 units, she sold an aggregate 144,008 Class A shares between March 26 and March 30 at weighted average prices around $1.14–$1.17 per share in sell-to-cover transactions the filing describes as non-discretionary. After these transactions, she holds 2,390,117 shares directly and 5,500 shares indirectly through her spouse, along with other unvested RSUs.
Zevia PBC filed a Form 144 reporting the vesting of restricted stock units and recent sales by an affiliate. The filing shows 10,776 restricted stock units vested on 03/11/2026. It also reports two past sales by Amy Taylor: 66,731 shares on 03/26/2026 and 66,501 shares on 03/27/2026.
Zevia PBC’s Chief Financial Officer, Satya Girish, reported both an equity award and a related tax sale of Class A Common Stock. On March 26, 2026, Girish acquired 453,901 RSUs under the 2021 Equity Incentive Plan, each representing one share, vesting in four annual installments starting on March 26, 2026.
On March 25, 2026, Girish sold 41,662 shares at a weighted average price of $1.1794 per share in a “sell to cover” transaction to satisfy tax withholding obligations tied to the settlement of 96,671 RSUs, which the filing states was not a discretionary trade. After these transactions, Girish directly owned 781,810 shares, including 696,584 RSUs subject to multi‑year vesting schedules.
Zevia PBC (ZVIA) submitted a Form 144 excerpt showing common stock transactions and restricted stock unit activity. The excerpt lists a vesting of restricted stock unit awards on 03/11/2026, an entry for securities sold during the past three months on 03/26/2026 associated with Amy Taylor, and broker information for Merrill Lynch at 225 Liberty Street.
Zevia PBC submitted a Form 144 notice concerning Common Stock in connection with the vesting of restricted stock unit awards dated 03/11/2026.
The filing identifies the security as Common Stock and references NYSE; the excerpt is limited and does not detail the number of shares to be sold, the planned sale method, or cash‑flow treatment.
Zevia PBC reported a proposed sale of 41,662 shares of Common Stock following the vesting of a restricted stock unit award on 03/11/2026, submitted on a Form 144 with Merrill Lynch listed as the broker.
The filing shows shares outstanding were 67,486,641 as of 03/25/2026. The Form 144 is a notice of an intended sale and does not by itself confirm execution.
Ginestro Suzanne Saltzman reported acquisition or exercise transactions in this Form 4 filing.
Zevia PBC director Suzanne Saltzman Ginestro received an equity award of 29,505 restricted stock units (RSUs) of Class A Common Stock. The grant was made at no cash cost to her and reflects stock-based compensation.
The 29,505 RSUs vest on the earlier of March 3, 2027 or Zevia’s 2026 annual meeting of stockholders, and are settled in shares within 30 days after vesting. Following this award, she holds 29,505 RSUs representing the right to receive an equal number of Class A shares if and when they vest.
Zevia PBC director Padraic L. Spence sold 40,000 shares of Class A Common Stock in an open-market transaction on March 3, 2026 at a weighted average price of $1.4379 per share. After this sale, he directly holds 1,555,417 shares, including 71,827 restricted stock units that will vest over time under previously established schedules.
Zevia PBC reports a proposed sale of 40,000 shares of Common Stock via Merrill Lynch, scheduled on 03/03/2026.
The filing notes those shares relate to a restricted stock unit award that vested on 01/17/2025.
Zevia PBC describes its business and risks as a zero‑sugar, naturally sweetened beverage company focused on soda, energy drinks and tea. Soda is its flagship line and represented approximately 95% of 2025 net sales, with products sold in more than 39,000 retail locations across the U.S. and Canada.
The company highlights its public benefit and Certified B Corporation status, emphasizing reduced sugar intake and avoidance of plastic bottles through exclusive use of aluminum cans. It estimates consumers have avoided over 103,000 metric tons of sugar and more than one billion plastic bottles since 2011.
Zevia remains loss‑making, reporting net losses of $11.1 million in 2025 and $23.8 million in 2024, and had an aggregate non‑affiliate equity market value of about $163.2 million as of June 30, 2025. As of February 20, 2026, there were 67,486,641 Class A and 7,614,823 Class B shares outstanding. Key risks include intense competition from large beverage companies and emerging brands, reliance on third‑party manufacturers and a limited supplier base for stevia and cans, exposure to tariffs on steel and aluminum, shifting consumer preferences, regulatory burdens, and climate and supply‑chain disruptions.